Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

FOXO3 and prostate cancer are reported together in 1 article.

Gene

FOXO3

HGNC
HGNC:3821
15articles
15mentions
3variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
218articles
218mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer.

PMID 39881138 | PMCID PMC11779938 | DOI 10.1038/s41598-025-85502-4 · Scientific reports · 2025 · 7 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneFOXO3“These miRNAs influence key genes, including FOXO3, NFAT3, PTEN, RHOA, VEGFA, SMAD7, and CDK2, playing significant roles in both tumor suppression and oncogenesis.”0.98hgnc_dict_v1
phenotypeprostate cancer“Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer.”0.98phenotype_alias_lexicon_v2
genePTEN“These miRNAs influence key genes, including FOXO3, NFAT3, PTEN, RHOA, VEGFA, SMAD7, and CDK2, playing significant roles in both tumor suppression and oncogenesis.”0.98hgnc_dict_v1
geneRHOA“These miRNAs influence key genes, including FOXO3, NFAT3, PTEN, RHOA, VEGFA, SMAD7, and CDK2, playing significant roles in both tumor suppression and oncogenesis.”0.98hgnc_dict_v1